Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk
Qiagen’s shares in the U.S. surged 15.9% to $55.13 on Tuesday after reports surfaced that the molecular diagnostics firm is exploring strategic options, including a potential sale, amid renewed takeover interest. The term often signals major moves like a sale; Qiagen has yet to comment.
